Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03065062 |
|---|---|
| Brief Title: | Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors |
| First Submitted : | February 6, 2017 |
| First Submitted that Met QC Criteria : | February 22, 2017 |
| First Posted : | February 27, 2017 |
| Last Update Submitted that Met QC Criteria : | July 24, 2020 |
| Last Update Posted : | July 27, 2020 |